- Investing Ideas
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
13
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
13 companies
Bonesupport Holding
Market Cap: SEK 14.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 220.20
7D
8.0%
1Y
-31.9%
Swedencare
Market Cap: SEK 3.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 22.00
7D
-0.2%
1Y
-41.5%
Cereno Scientific
Market Cap: SEK 1.5b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.83
7D
-2.5%
1Y
-48.1%
Devyser Diagnostics
Market Cap: SEK 1.1b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 66.10
7D
6.3%
1Y
-55.0%
Xspray Pharma
Market Cap: SEK 800.4m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 16.88
7D
10.6%
1Y
-65.7%
Cinclus Pharma Holding
Market Cap: SEK 556.6m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.96
7D
0.2%
1Y
-30.4%
Enzymatica
Market Cap: SEK 450.3m
A life science company, develops and sells medical devices for infectious diseases.
ENZY
SEK 1.86
7D
-1.3%
1Y
-31.8%
Moberg Pharma
Market Cap: SEK 444.2m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 9.45
7D
1.3%
1Y
4.9%
Mendus
Market Cap: SEK 442.3m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.94
7D
6.6%
1Y
-26.7%
Alzinova
Market Cap: SEK 235.1m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.16
7D
38.1%
1Y
-22.7%
Diamyd Medical
Market Cap: SEK 159.6m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 1.03
7D
-0.2%
1Y
-90.4%
Biovica International
Market Cap: SEK 146.0m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.50
7D
-5.3%
1Y
-24.0%
IDL Diagnostics
Market Cap: SEK 99.1m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.43
7D
4.9%
1Y
-22.7%